ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months

BACKGROUND: The efficacy of an extended-release injectable moxidectin (0.5 mg/kg) suspension (ProHeart® 12) (PH 12) in preventing the development of Dirofilaria immitis in dogs for 12 months was investigated in laboratory and field studies in the USA. METHODS: In each of two laboratory studies, 20 d...

Descripción completa

Detalles Bibliográficos
Autores principales: McTier, Tom L., Kryda, Kristina, Wachowski, Martha, Mahabir, Sean, Ramsey, Deborah, Rugg, Doug, Mazaleski, Mark, Therrien, Carol, Adams, Eric, Wolff, T., Bowman, Dwight D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660952/
https://www.ncbi.nlm.nih.gov/pubmed/31349867
http://dx.doi.org/10.1186/s13071-019-3632-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660952/
https://www.ncbi.nlm.nih.gov/pubmed/31349867
http://dx.doi.org/10.1186/s13071-019-3632-3

Ejemplares similares